Search results for "Uterine Cervical Neoplasms"

showing 10 items of 165 documents

Vaginal-assisted laparoscopic radical hysterectomy: rationale, technique, results.

2012

The authors conclude that vaginal-assisted laparoscopic radical hysterectomy is an oncologic viable alternative to abdominal radical hysterectomy, laparoscopic-assisted radical vaginal hysterectomy, totally laparoscopic radical hysterectomy, and robotic radical hysterectomy.

AdultUterine Cervical Neoplasmmedicine.medical_specialtymedicine.medical_treatmentUterine Cervical NeoplasmsUrologic complicationPostoperative ComplicationsUrologic complicationsmedicineHysterectomy VaginalScientific PapersHumansRadical hysterectomyEndometrial NeoplasmRadical HysterectomyStage (cooking)Survival analysisAgedNeoplasm StagingCervical cancerAged 80 and overHysterectomybusiness.industryPostoperative complicationMiddle Agedmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurvival AnalysisSurgeryEndometrial NeoplasmsLaparoscopic radical hysterectomymedicine.anatomical_structureTreatment OutcomeVaginaCervical cancerSurgeryFemaleLaparoscopyPostoperative ComplicationSurvival AnalysiCervical cancer; Laparoscopic radical hysterectomy; Urologic complicationsNeoplasm GradingLaparoscopic radical hysterectomybusinessHumanJSLS : Journal of the Society of Laparoendoscopic Surgeons
researchProduct

Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival

1999

Since detailed knowledge regarding the pathophysiological properties—which in turn are responsible for differences in contrast enhancement—remain fairly undetermined, it was the aim of this study (i) to examine the association of standard and pharmacokinetic analysis of time-intensity curves in dynamic MRI with histomorphological markers of tumor angiogenesis (microvessel density [MVD]; vascular endothelial growth factor [VEGF]) and (ii) to determine the ultimate value of a histomorphological and a dynamic MRI approach by correlation of those data with disease outcome in patients with primary cancer of the uterine cervix. Pharmacokinetic parameters (amplitude A, exchange rate constantk 21) …

AdultVascular Endothelial Growth Factor APathologymedicine.medical_specialtyTime FactorsBiophysicsUterine Cervical NeoplasmsEndothelial Growth Factorschemistry.chemical_compoundText miningPharmacokineticsBiomarkers TumormedicineHumansRadiology Nuclear Medicine and imagingSurvival analysisCervical cancerLymphokinesNeovascularization PathologicRadiological and Ultrasound TechnologyVascular Endothelial Growth Factorsbusiness.industryMicrocirculationGold standard (test)Middle Agedmedicine.diseaseMagnetic Resonance ImagingPathophysiologySurvival RateVascular endothelial growth factorchemistryDynamic contrast-enhanced MRIFemaleNuclear medicinebusinessMagnetic Resonance Materials in Physics, Biology and Medicine
researchProduct

Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage

2012

Background: Population-based studies on endometrial cancer providing survival estimates by age, histology, and stage have been sparse. We aimed to derive most up-to-date and detailed survival estimates for endometrial cancer patients in Germany. Methods: We used a pooled German national dataset including data from 11 cancer registries covering a population of 33 million people. 30,906 patients diagnosed with endometrial cancer in 1997-2006 were included. Period analysis was performed to calculate 5-year relative survival (RS) in 2002-2006. Trends in survival between 2002 and 2006 were examined using model-based period analysis. Age-adjustment was performed using five age groups (15-44, 45-5…

Adultmedicine.medical_specialtyAdolescentPopulationUterine Cervical NeoplasmsAge DistributionGermanyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRegistriesStage (cooking)educationSurvival analysisAgedNeoplasm StagingCervical cancereducation.field_of_studyRelative survivalbusiness.industryEndometrial cancerAge FactorsCancerHematologyGeneral MedicineMiddle AgedPrognosismedicine.diseaseSurvival AnalysisSurgerySurvival RateOncologyFemaleSarcomabusinessActa Oncologica
researchProduct

Successful treatment of a young patient with locally advanced clear cell adenocarcinoma of the uterine cervix undergoing chemoradiation followed by r…

2014

Clear cell adenocarcinoma (CCAC) of the uterine cervix is a rare variant of cervical adenocarcinoma accounting for approximately 4-9% of this disease. Given the rarity of this pathological entity, the optimal treatment management is far from being defined. Earlier evidence suggested that the prognosis of patients bearing cervical CCAC is worse than with other histotypes, thus making the investigation of multimodal treatment strategies clinically worthwhile. Herein, we report the first case of locally advanced, large size cervical CCAC in a young woman who was triaged to concomitant chemoradiotherapy followed by radical surgery and experienced a pathologically assessed optimal response to th…

Adultmedicine.medical_specialtyAdvanced clear cell adenocarcinomaUterine Cervical NeoplasmRadical surgeryUterine Cervical NeoplasmsDisease-Free SurvivalObstetrics and gynaecologyadenocarcinoma uterine cervixUterine cervixmedicineHumansCombined Modality TherapyClear-cell adenocarcinomaRadical surgeryPathologicalSettore MED/08 - ANATOMIA PATOLOGICAbusiness.industryObstetrics and GynecologyMultimodal therapyChemoradiotherapy Adjuvantmedicine.diseaseMultimodal approachCombined Modality TherapyImmunohistochemistryMagnetic Resonance ImagingSurgeryChemoradiationReproductive MedicineAdenocarcinomaFemalebusinessChemoradiotherapyAdenocarcinoma Clear CellHuman
researchProduct

Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer

2007

Patients with cervical cancer frequently suffer from anemia. This two-stage, adaptive-design study investigated the effect of anemia correction with epoetin beta on treatment outcomes. Patients with stage IIB–IVA cervical cancer received radiochemotherapy (RCT) and were randomized to epoetin 150 IU/kg three times weekly (n = 34) or standard care (control; n = 40) for up to 12 weeks. Primary end point for stage 1 aimed to establish a correlation between anemia correction and treatment failure (no complete response or relapsing within 6 months after RCT initiation) as a proof of concept before moving into stage 2. Secondary end points included progression/relapse-free survival, overall surviv…

Adultmedicine.medical_specialtyAnemiaInjections Subcutaneousmedicine.medical_treatmentUterine Cervical NeoplasmsRisk AssessmentGastroenterologyDrug Administration Schedulelaw.inventionRandomized controlled trialReference ValueslawInternal medicinemedicineClinical endpointHumansAdverse effectErythropoietinSurvival analysisNeoplasm StagingProbabilityCervical cancerChemotherapyEpoetin betaDose-Response Relationship Drugbusiness.industryObstetrics and GynecologyAnemiaMiddle Agedmedicine.diseaseCombined Modality TherapyImmunohistochemistrySurvival AnalysisRecombinant ProteinsSurgeryLogistic ModelsTreatment OutcomeOncologyChemotherapy AdjuvantFemaleRadiotherapy AdjuvantbusinessFollow-Up StudiesInternational Journal of Gynecologic Cancer
researchProduct

Prevalence of human papillomavirus types in women screened by cytology in Germany.

2007

Incidence and mortality rates of cervical cancer are higher in Germany than in other Western European countries. Type-specific human papillomavirus (HPV) distribution was investigated for the first time in Germany in an epidemiological study including 8,101 women. Women above the age of 30 years, self-referring for cervical cancer screening, were enrolled in two study centers in Hannover (Northern Germany) and Tubingen (Southern Germany). Participants were screened by the Pap smear and the hybrid capture 2 (HC2) test using the high-risk probe. All samples that were positive by the HC2 test were genotyped using the prototype PGMY09/11 PCR line blot assay. Most women in the study population h…

Adultmedicine.medical_specialtyCytodiagnosisUterine Cervical NeoplasmsCervical intraepithelial neoplasiaCohort StudiesSpecies SpecificityRisk FactorsVirologyGermanyEpidemiologymedicinePrevalenceHumansPapillomaviridaePapillomaviridaeGynecologyCervical cancerbiologybusiness.industryObstetricsMortality rateIncidence (epidemiology)Papillomavirus InfectionsMiddle Agedbiology.organism_classificationmedicine.diseaseVirologyVaccinationInfectious DiseasesPopulation studyFemalebusinessCarcinoma in SituJournal of medical virology
researchProduct

About invasive cervical cancer: a French population based study between 1998 and 2010

2015

Abstract Objectives The new French cancer plan provides the implementation of organized screening. To make an assessment of the situation, we aim to describe clinical, tumor and survival characteristics of patients with invasive cervical cancer. Study design Data on women suffering from invasive cervical cancer and diagnosed from 1998 to 2010 were provided by the Cote d’Or breast cancer registry. Survival was described using the Kaplan–Meier method and prognostic factors of survival were estimated in a Cox proportional hazard model. Results On the whole, 1019 cancers have been collected including 311 (30.5%) invasive ones. The peak incidence was between 40 and 49 years, with an average age …

Adultmedicine.medical_specialtyDelayed DiagnosisPopulationUterine Cervical NeoplasmsCervix UteriBreast cancerInternal medicineEpidemiology of cancerHumansMedicineNeoplasm InvasivenessRegistrieseducationSurvival rateEarly Detection of CancerAgedNeoplasm StagingRetrospective StudiesCervical cancerGynecologyeducation.field_of_studybusiness.industryProportional hazards modelIncidenceIncidence (epidemiology)Obstetrics and GynecologyCancerMiddle AgedPrognosismedicine.diseaseSurvival AnalysisReproductive MedicineCarcinoma Squamous CellPatient ComplianceFemaleFrancebusinessFollow-Up StudiesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

A multicentric randomized study comparing two techniques of magnification assisted loop excision of high-grade cervical intraepithelial neoplasia: vi…

2013

Purpose: To compare loop excisions of cervical intraepithelial neoplasia grade 2 or worse (CIN 2+) under video exoscopy, or colposcopic guidance, with respect to safety and effectiveness. Methods: Prospective multicentric randomized trial of 300 patients, undergoing loop excision for CIN 2+ either under video exoscopy (group A) or colposcope (group B) guidance. Intra- and post-operative complications, resection margins, and removed cervical volume in both groups were evaluated. Results: 19.3% of patients in video exoscopy group and 15.5% in colposcopy group (p = 0.67) had transformation zone (TZ) 3. 45/151 (29.8%) of group A patients and 48/149 (32.2%) of group B patients underwent top-hat …

Adultmedicine.medical_specialtyElectrosurgeryMagnificationUterine Cervical NeoplasmsVideo-Assisted SurgeryCervix UteriExoscopylaw.inventionYoung AdultPostoperative ComplicationsRandomized controlled trialCervical intraepithelial neoplasia grade 2lawPregnancyLEEPMedicineHumansVolume removedLoop excisionProspective StudiesAgedColposcopyAged 80 and overmedicine.diagnostic_testbusiness.industryObstetrics and GynecologyGeneral MedicineMiddle AgedUterine Cervical DysplasiaSurgeryColposcopyHigh Grade Cervical Intraepithelial NeoplasiaColposcopFemaleSafetyNeoplasm Recurrence LocalbusinessArchives of gynecology and obstetrics
researchProduct

Risk factors of female cancers in Ragusa population (Sicily). 2. Breast cancer.

1989

A case-control study on breast, cervix and corpus uteri cancer cases registered in Ragusa between January 1, 1983 and June 30, 1985 has been conducted. Information on risk factors has been obtained by means of a structured questionnaire. Risk factors for breast cancer were: few pregnancies (1-2 vs greater than 4 OR 2.14, 95% CL 1.13-4.04), few children (for postmenopausal only, chi trend 4.84), previous breast disease (OR 1.97, 95% CL 1.20-3.23), family history (OR 3.57, 95% CL 1.92-6.63), alcohol (OR 1.68, 95% CL 1.12-2.53), high socioeconomical status (1 vs 4 OR 2.93, 95% CL 1.22-70.03). A protective role was evident for: early age at first birth (for premenopausal only, less than 20 vs g…

Adultmedicine.medical_specialtyEpidemiologyPopulationUterine Cervical NeoplasmsBreast NeoplasmsBreast cancerPregnancyRisk FactorsmedicineHumansFamily historyeducationCervixSicilyAgedGynecologyAged 80 and overeducation.field_of_studybusiness.industryMiddle Agedmedicine.diseasemedicine.anatomical_structureRisk factors for breast cancerCase-Control StudiesUterine NeoplasmsMenarcheFemaleBreast diseasebusinessBreast feedingEuropean journal of epidemiology
researchProduct

Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors.

2005

Few data exist on attendance for cervical and breast cancer screening, breast self-examination and knowledge about risk factors for cervical cancer among German women. A population-based survey was performed in the city of Bielefeld in Germany.A questionnaire was mailed to 1500 randomly selected women age 25 to 75. Of those, 540 questionnaires were returned and 532 were analysed.Women participating in the survey considered themselves well informed about possibilities for early detection of breast cancer (84.0%). Most information was received from office-based gynaecologists (82.4%). 82.8% had a breast examination by a medical doctor annually and 43.1% practised breast self-examination every…

Adultmedicine.medical_specialtyHealth Knowledge Attitudes PracticePopulationUterine Cervical NeoplasmsBreast NeoplasmsBreast cancer screeningBreast cancerPatient Education as TopicRisk FactorsGermanySurveys and QuestionnairesCancer screeningMedicineMammographyHumansRisk factoreducationPapillomaviridaePhysical ExaminationAgedGynecologyCervical cancerVaginal Smearseducation.field_of_studyMotivationmedicine.diagnostic_testbusiness.industryObstetricsPublic Health Environmental and Occupational HealthBreast Self-ExaminationMiddle AgedPatient Acceptance of Health Caremedicine.diseasePopulation studyFemalebusinessMammographyPapanicolaou TestEuropean journal of public health
researchProduct